Last updated: 2026-10-13 09:16:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Sensus Healthcare, Inc. (SRTS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.94, with a market capitalisation of $48.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.66 to $5.49. This page covers its latest market performance, valuation, price trends and company information.
$48.56M | |
$2.93 | |
$15.25 | |
$1.76 | |
$2.95 | |
5.69K | |
29.12K | |
-- | |
$5.49 | |
$2.66 | |
-- | |
-- |
Sensus Healthcare, Inc. (SRTS) is trading at $2.94 in pre-market trading as of 2026-10-12 23:31:00, down 0.44% ($0.01) from the previous close of $2.95
Pre-market trading shows how investors are pricing SRTS before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Sensus Healthcare, Inc. (SRTS) moved from $2.98 to $2.94, representing a decline of 1.24% ($0.04).
The stock traded between $2.90 and $3.08 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 16.43 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 10.0%
SRTS is currently trading at $2.94, placing it 10.0% of the way from its 52-week low of $2.66 to its 52-week high of $5.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 60 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sensus Healthcare, Inc. (SRTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.